Difficult asthma

Proceedings of the American Thoracic Society

Volumn 3, Issue 1, 2006, Pages 116-123

  Strek, Mary E ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Asthma; Diagnosis; Difficult asthma; Management

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CALCIUM; CORTICOSTEROID; CYCLOSPORIN; FLUNISOLIDE; FLUTICASONE; FORMOTEROL; GOLD; IMMUNOGLOBULIN E ANTIBODY; ISOPRENALINE; METHOTREXATE; METHYLPREDNISOLONE; MOMETASONE FUROATE; NONSTEROID ANTIINFLAMMATORY AGENT; OMALIZUMAB; OMEPRAZOLE; PREDNISONE; SALBUTAMOL; SALMETEROL; THEOPHYLLINE; TRIAMCINOLONE; VITAMIN D;

ALLERGIC RHINITIS; ANAPHYLAXIS; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DISEASE EXACERBATION; DRUG EFFICACY; ECHOCARDIOGRAPHY; FIBEROPTIC BRONCHOSCOPY; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION TEST; METERED DOSE INHALER; OCCUPATIONAL EXPOSURE; OSTEOPENIA; PATIENT COMPLIANCE; PEAK EXPIRATORY FLOW; PHENOTYPE; PROVOCATION TEST; REVIEW;

ASTHMA; BRONCHODILATOR AGENTS; DIAGNOSIS, DIFFERENTIAL; GLUCOCORTICOIDS; HUMANS; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 33644504507     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200510-115JH     Document Type: Review

References (57)

1. Barnes PJ, Woolcock AJ. Difficult asthma. Eur Respir J 1998;12:1209-1218.
2. ERS Task Force. Difficult/therapy-resistant asthma. Eur Respir J 1999;13:1198-1208.
3. Robinson DS, Campbell DA, Durham SR, Pfeffer J, Barnes PJ, Chung KF. Systematic assessment of difficult-to-treat asthma. Eur Respir J 2003;22:478-483.
4. National Asthma Education and Prevention Program. Expert Panel Report 2: guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health; 1997. NIH Publication No. 97-4051.
5. Turner-Warwick M. Epidemiology of nocturnal asthma. Am J Med 1988;85:6-8.
6. American Thoracic Society. American Thoracic Society statement: guidelines for methacholine and exercise challenge testing - 1999. Am J Respir Crit Care Med 2000;161:309-329.
7. Rhu JH, Myers JL, Swenson SJ. Bronchiolar disorders. Am J Respir Crit Care Med 2003;168:1277-1292.
8. Lynch JP III, Kazerooni EA, Gay SE. Pulmonary sarcoidosis. Clin Chest Med 1997;18:755-785.
9. Snashall PD, Chung KF. Airway obstruction and bronchial hyperresponsiveness in left ventricular failure and mitral stenosis. Am Rev Respir Dis 1991;144:945-956.
10. Smoller JW, Pollack MH, Otto MW, Rosenbaum JF, Kradin RL. Panic anxiety, dyspnea, and respiratory disease. Am J Respir Crit Care Med 1996;154:6-17.
11. Morris MJ, Deal LE, Bean DR, Grbach VX, Morgan JA. Vocal cord dysfunction in patients with exertional dyspnea. Chest 1999;116:1676-1682.
12. Gehlbach BK, Geppert E. The pulmonary manifestations of left heart failure. Chest 2004;125:669-682.
13. Weiss ST, Shore SS. Obesity and asthma. Am J Respir Crit Care Med 2004;169:963-968.
14. Silverman RA, Boudreaux ED, Woodruff PG, Clark S, Camargo CA Jr. Cigarette smoking among asthmatic adults presenting to 64 emergency departments. Chest 2003;123:1472-1479.
15. Rome LA, Lippman ML, Dalsey WC, Taggart P, and Pomerantz S. Prevalence of cocaine use and its impact on asthma exacerbation in an urban population. Chest 2000;117:1324-1329.
16. Chaudhuri R, Livingston E, McMahon AD, Thomson L, Borland W, Thomson NC. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am J Respir Crit Care Med 2003;168:1308-1311.
17. Tunnicliffe WS, Fletcher TJ, Hammond K, Roberts K, Custovic A, Simpson A, Woodcock A, Ayres JG. Sensitivity and exposure to indoor allergens in adults with differing asthma severity. Eur Respir J 1999;13:654-659.
18. Mapp CE, Boschetto P, Maestrelli P, Fabbri LM. Occupational asthma. Am J Respir Crit Care Med 2005;172:280-305.
19. Le Moual N, Siroux V, Pin I, Kauffman F, Kennedy SM, for the Epidemiological Study on the Genetics and Environment of Asthma (EGEA). Asthma severity and exposure to occupational asthmogens. Am J Respir Crit Care Med 2005;172:440-445.
20. Troisi RJ, Speizer FE, Willett WC, Trichopoulos D, Rosner B. Menopause, postmenopausal estrogen preparations, and the risk of adultonset asthma: a prospective cohort study. Am J Respir Crit Care Med 1995;152:1183-1188.
21. Varraso R, Siroux V, Maccario J, Pin I, Kauffman F. Asthma severity is associated with body mass index and early menarche in women. Am J Respir Crit Care Med 2005;171:334-339.
22. Skobeloff EM, Spivey WH, Silverman R, Eskin BA, Harchelroad F, Alessi TV. The effect of the menstrual cycle on asthma presentations in the emergency department. Arch Intern Med 1996;156:1837-1840.
23. Busse WW, Kiecolt-Glaser JK, Coe C, Martin RJ, Weiss ST, Parker SR. Stress and asthma. Am J Respir Crit Care Med 1995;151:249-252.
24. Hasler G, Gergen PJ, Kleinbaum DG, Ajdacic V, Rössler DE, Angst J. Asthma and panic in young adults. Am J Respir Crit Care Med 2005;171:1224-1230.
25. Liu LY, Coe CL, Swenson CA, Kelly EA, Kita H, Busse WW. School examinations enhance airway inflammation to antigen challenge. Am J Respir Crit Care Med 2002;165:1062-1067.
26. Thomas M, Griffiths C. Asthma and panic. Am J Respir Crit Care Med 2005;171:1197-1201.
27. Allergic Rhinitis and Its Impact on Asthma. Workshop report. J Allergy Clin Immunol 2001;108:5198-5240.
28. Wilson AM, Orr LC, Sims EJ, Dempsey OJ, Lipworth BJ. Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma. Am J Respir Crit Care Med 2000;162:1297-1301.
29. Field SK, Underwood M, Rollin B, Cowie RL. Prevalence of gastroesophageal reflux symptoms in asthma. Chest 1996;109:316-322.
30. Leggett JJ, Johnston BT, Mills M, Gamble J, Heaney LG. Prevalence of gastroesophageal reflux in difficult asthma: relationship to asthma outcome. Chest 2005;127:1097-1098.
31. National Asthma Education and Prevention Program. Expert Panel Report: guidelines for the diagnosis and management of asthma: update on selected topics 2002. Bethesda, MD; National Institutes of Health; 2003. NIH Publication No. 02-5074.
32. Barnes PJ. Distribution of receptor targets in the lung. Proc Am Thorac Soc 2004;1:345-351.
33. Renaud Louis L, Law CK, Bron AO, Roldaan AC, Radermecker M, Djukanović R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 2000;161:9-16.
34. Brinke A-t, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH. "Refractory" eosinophil airway inflammation in severe asthma. Am J Respir Crit Care Med 2004;170:601-605.
35. Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B. Low-dose inhaled corticosteroids and the prevention of death from asthma. New Engl J Med 2000;343:332-336.
36. Wempe JB, Postma DS, Breederveld N, Alting-Hebing A, van der Mark TW, Koëter GH. Separate and combined effects of corticosteroids and bronchodilators on airflow obstruction and airway hyperresponsiveness in asthma. J Allergy Clin Immunol 1992;89:679-687.
37. Hanania NA, Sharafkhaneh A, Barber R, Dickey BF. Beta-agonist intrinsic efficacy. Am J Respir Crit Care Med 2002;165:1353-1358.
38. Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996;153:1481-1488.
39. Masoli M, Weatherall M, Hold S, Beasley R. Moderate dose inhaled corticosteroids plus almeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Thorax 2005;60:730-734.
40. Pizzichini E, Leff JA, Reiss L, Hendeles L, Boulet L-P,Wei LX, Efthimiadis AE, Zhang J, Hargreave FE. Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial. Eur Respir J 1999;14:12-18.
41. Minoguchi K, Kohno Y, Minoguchi H, Kihara N, Sano Y, Yasuhara H, Adachi M. Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast. Chest 2002;121:732-738.
42. Djukanović R, Wilson SJ, Kraft M, Jarjour NN, Steel M, Fan Chung K, Bao W, Fowler-Taylor A, Matthews J, Busse WW, et al. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. Am J Respir Crit Care Med 2004;170:583-593.
43. Marshall GD Jr, Sorkness CA. IgE-blocking therapy for difficult-to-treat asthma: a brief review. Manag Care 2004;(March):45-50.
44. Marin MG. Low-dose methotrexate spares steroid usage in steroid-dependent asthmatic patiens: a meta-analysis. Chest 1997;112:29-33.
45. Erzurum SC, Leff JA, Cockran JE, Ackerson LM, Szefler SJ, Martin RJ, Cott GR. Lack of benefit of methotrexate in severe, steroid-dependent asthma. Ann Intern Med 1991;114:353-360.
46. Ogirala RG, Sturm TM, Aldrich TK, Meller FF, Pacia EF, Keane AM, Finkel RI. Single, high-dose intramuscular triamcinolone acetonide versis weekly oral methotrexate in life-threatening asthma: a double-blind study. Am J Respir Crit Care Med 1995;152:1461-1466.
47. Diette GB, Wu AW, Skinner EA, Markson L, Clark RD, McDonald RC, Healy JP Jr, Huber M, Steinwachs DM. Treatment patterns among adult patients with asthma. Arch Intern Med 1999;159:2697-2704.
48. Krishnan JA, RiekertKA, McCoy JV, Stewart DY, Schmidt S, Chanmugam A, Hill P, Rand CS. Corticosteroid use after hospital discharge among high-risk adults with asthma. Am J Respir Crit Care Med 2004;170:1281-1285.
49. Stempel DA, Stoloff SW, Carranza Rosenzweig JR, Stanford RH, Ryskina KL, Legorreta AP. Adherence to asthma controller medication regimens. Respir Med 2005;99:1263-1267.
50. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-497.
51. Wenzel SE. Severe asthma in adults. Am J Respir Crit Care Med 2005;172:149-160.
52. Szefler SJ, Leung DYM. Glucocorticoid-resistant asthma: pathogenesis and clinical implications for management. Eur Respir J 1997;10:1640-1647.
53. Ayres JG, Miles JF, Barnes PJ. Brittle asthma. Thorax 1998;53:315-321.
54. McFadden ER. Acute severe asthma. Am J Respir Crit Care Med 2003;168:740-759.
55. Paganin F, Seneterre E, Chanez P, Daures JP, Bruel JM, Michel FB, Bousquet J. Computed tomography of the lungs in asthma: influence of disease severity and etiology. Am J Respir Crit Care Med 1996;153:110-114.
56. Irwin JRS, Curley FJ, French CL. Difficult-to-control asthma. Chest 1993;103:1662-1669.
57. Heaney LG, Conway E, Kelly C, Johnston BT, English C, Stevenson M, Gamble J. Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol. Thorax 2003;58:561-566.